1. Home
  2. QLGN vs SGLY Comparison

QLGN vs SGLY Comparison

Compare QLGN & SGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QLGN
  • SGLY
  • Stock Information
  • Founded
  • QLGN 1996
  • SGLY 2001
  • Country
  • QLGN United States
  • SGLY United States
  • Employees
  • QLGN N/A
  • SGLY N/A
  • Industry
  • QLGN Biotechnology: Pharmaceutical Preparations
  • SGLY
  • Sector
  • QLGN Health Care
  • SGLY
  • Exchange
  • QLGN Nasdaq
  • SGLY Nasdaq
  • Market Cap
  • QLGN 4.7M
  • SGLY 4.4M
  • IPO Year
  • QLGN N/A
  • SGLY 2008
  • Fundamental
  • Price
  • QLGN $2.80
  • SGLY $1.07
  • Analyst Decision
  • QLGN
  • SGLY
  • Analyst Count
  • QLGN 0
  • SGLY 0
  • Target Price
  • QLGN N/A
  • SGLY N/A
  • AVG Volume (30 Days)
  • QLGN 2.5M
  • SGLY 42.6K
  • Earning Date
  • QLGN 07-21-2025
  • SGLY 08-26-2025
  • Dividend Yield
  • QLGN N/A
  • SGLY N/A
  • EPS Growth
  • QLGN N/A
  • SGLY N/A
  • EPS
  • QLGN N/A
  • SGLY N/A
  • Revenue
  • QLGN N/A
  • SGLY $2,172,036.00
  • Revenue This Year
  • QLGN N/A
  • SGLY N/A
  • Revenue Next Year
  • QLGN N/A
  • SGLY N/A
  • P/E Ratio
  • QLGN N/A
  • SGLY N/A
  • Revenue Growth
  • QLGN N/A
  • SGLY N/A
  • 52 Week Low
  • QLGN $2.74
  • SGLY $0.54
  • 52 Week High
  • QLGN $13.50
  • SGLY $7.65
  • Technical
  • Relative Strength Index (RSI)
  • QLGN 35.34
  • SGLY 53.38
  • Support Level
  • QLGN $2.77
  • SGLY $0.99
  • Resistance Level
  • QLGN $3.29
  • SGLY $1.14
  • Average True Range (ATR)
  • QLGN 0.53
  • SGLY 0.05
  • MACD
  • QLGN -0.06
  • SGLY 0.00
  • Stochastic Oscillator
  • QLGN 1.65
  • SGLY 66.67

About QLGN Qualigen Therapeutics Inc.

Qualigen Therapeutics Inc is an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's program, QN-302, is an investigational small-molecule G-quadruplexes (G4)-selective transcription inhibitor with binding affinity to G4s prevalent in cancer cells.

About SGLY Singularity Future Technology Ltd.

Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: